I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Study Number

3454822

Phase

Age Group

Adult

Principal Investigator

Purpose

The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.

Check your eligibility for this trial

Check now

Full Title

( I-SPY 2) Investigation of Serial Studies to Predict your Therapeutic Response with Imaging and Molecular Analysis 2

ClinicalTrials.Gov ID

NCT01042379

Get more information and eligibility criteria for this trial at ClinicalTrials.gov

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.